Quantcast

Latest Allergan Inc. Stories

2014-08-20 08:28:21

Allergan, the makers of ACZONE®(dapsone) Gel 5% team up with celebrity makeup artist Julianne Kaye on new video tutorial IRVINE, Calif., Aug. 20, 2014 /PRNewswire/ -- Renowned beauty expert and makeup artist to the stars Julianne Kaye is partnering with Allergan, the makers of ACZONE® (dapsone) Gel 5%, the No. 1 prescribed retinoid-free acne brand in the U.S., to offer expert skincare and makeup tips in an exclusive video posted today on www.aczone.com. 1 ACZONE® Gel is a...

2014-08-19 08:30:23

IRVINE, Calif., Aug. 19, 2014 /PRNewswire/ -- Nearly half (46 percent) of women age 45 or older who experience symptoms of overactive bladder (OAB) say their current treatment does not address their OAB symptoms, according to a recent survey (n=1,017) conducted by The Harris Poll on behalf of Allergan, Inc.(1) An estimated 39 million Americans are currently living with OAB,(2) a common, sometimes disabling condition(3) often associated with a considerable impact on patients with symptoms...

2014-08-15 16:24:18

LAVAL, Quebec, Aug. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan, Inc. ("Allergan") (NYSE: AGN) to 5:00 p.m., New York City time, on December 31, 2014. The exchange offer was previously scheduled to expire at 5:00 p.m., New York City time today, Friday, August 15, 2014. All other terms and conditions of the exchange offer...

2014-08-14 20:22:14

MarketOptimizer.org adds "Australia Bariatric Surgery Devices Market Outlook to 2020" to its store. DALLAS, Aug. 14, 2014 /PRNewswire-iReach/ -- "Australia Bariatric Surgery Devices Market Outlook to 2020 , provides key market data on the Australia Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Bariatric Stapling Devices, Gastric Bands and Gastric Balloons. Photo -...

2014-08-11 20:24:49

QUEBEC, Aug. 11, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) announced that the Company has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The information request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The effect of the second request is to...

2014-08-06 16:28:46

ISS Raises Significant Concerns about Corporate Governance Practices at Allergan LAVAL, Quebec and NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX: VRX) and Pershing Square Capital Management, L.P. ("Pershing Square") today commented on Institutional Shareholder Services' ("ISS") recommendation in support of Pershing Square's effort to call a special meeting of Allergan shareholders. Pershing Square is seeking to call a special...

2014-08-01 16:23:51

Desperate Allergan Attempt to Interfere with the Special Meeting LAVAL, Quebec and NEW YORK, Aug. 1, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management, L.P. today responded to the filing of a federal lawsuit by Allergan, Inc. (NYSE: AGN) in California. The complaint makes baseless claims about Valeant and Pershing Square regarding the tender offer rules. Allergan's true purpose in bringing the litigation is an attempt to...

2014-07-31 08:36:44

Winners to be Recognized by Research and Academic Leaders on October 28th at the 2014 Prix Galien USA Awards Ceremony in New York City NEW YORK, July 31, 2014 /PRNewswire/ -- The Galien Foundation today announced the 2014 nominees for the eighth annual Prix Galien USA Awards. The Prix Galien Award is considered the biomedical industry's highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices....

2014-07-24 08:33:41

LAVAL, Quebec, July 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements...

2014-07-18 23:03:28

ReportsnReports.com adds “United States Bariatric Surgery Devices Market Outlook to 2020” to its store. The objective is to provide information that represents the most up-to-date data of the industry possible. Dallas, TX (PRWEB) July 18, 2014 "United States Bariatric Surgery Devices Market Outlook to 2020" provides key market data on the United States Bariatric Surgery Devices market. The report provides value in millions of US dollars, volume (in units), and average prices...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related